Circulating fibrosis markers, eosinophil cationic protein and eosinophil protein X in patients with Wuchereria bancrofti infection: association with clinical status.
Identifieur interne : 003957 ( PubMed/Curation ); précédent : 003956; suivant : 003958Circulating fibrosis markers, eosinophil cationic protein and eosinophil protein X in patients with Wuchereria bancrofti infection: association with clinical status.
Auteurs : P. Esterre [Polynésie française] ; C. Plichart ; M O Huin-Blondey ; L N Nguyen ; D. Hartmann ; S. Guerret ; C M Reimert ; S. Ricard-BlumSource :
- Parasite (Paris, France) [ 1252-607X ] ; 2006.
Descripteurs français
- KwdFr :
- Adulte, Adulte d'âge moyen, Animaux, Facteurs immunologiques (sang), Femelle, Fibrose, Filariose lymphatique (anatomopathologie), Filariose lymphatique (parasitologie), Filariose lymphatique (sang), Filarioses (anatomopathologie), Filarioses (parasitologie), Filarioses (sang), Humains, Marqueurs biologiques (sang), Mâle, Neurotoxine dérivée des éosinophiles (sang), Polynésie, Protéine cationique de l'éosinophile (sang), Test ELISA, Wuchereria bancrofti (immunologie).
- MESH :
- anatomopathologie : Filariose lymphatique, Filarioses.
- immunologie : Wuchereria bancrofti.
- parasitologie : Filariose lymphatique, Filarioses.
- sang : Facteurs immunologiques, Filariose lymphatique, Filarioses, Marqueurs biologiques, Neurotoxine dérivée des éosinophiles, Protéine cationique de l'éosinophile.
- Adulte, Adulte d'âge moyen, Animaux, Femelle, Fibrose, Humains, Mâle, Polynésie, Test ELISA.
English descriptors
- KwdEn :
- Adult, Animals, Biomarkers (blood), Elephantiasis, Filarial (blood), Elephantiasis, Filarial (parasitology), Elephantiasis, Filarial (pathology), Enzyme-Linked Immunosorbent Assay, Eosinophil Cationic Protein (blood), Eosinophil-Derived Neurotoxin (blood), Female, Fibrosis, Filariasis (blood), Filariasis (parasitology), Filariasis (pathology), Humans, Immunologic Factors (blood), Male, Middle Aged, Polynesia, Wuchereria bancrofti (immunology).
- MESH :
- chemical , blood : Biomarkers, Eosinophil Cationic Protein, Eosinophil-Derived Neurotoxin, Immunologic Factors.
- geographic : Polynesia.
- blood : Elephantiasis, Filarial, Filariasis.
- immunology : Wuchereria bancrofti.
- parasitology : Elephantiasis, Filarial, Filariasis.
- pathology : Elephantiasis, Filarial, Filariasis.
- Adult, Animals, Enzyme-Linked Immunosorbent Assay, Female, Fibrosis, Humans, Male, Middle Aged.
Abstract
We measured the concentrations of several circulating fibrosis markers (type I collagen I, type III procollagen, hyaluronan) and eosinophil granule proteins (ECP and EPX) in lymphatic filariosis patients to investigate their relationship with clinical, parasitological and immunological data. This study was conducted in Polynesian patients with various stages of the disease (acute lymphangitis, chyluria, hydrocoele, elephantiasis), a closely related microbial lymphangitis and endemic controls. We observed modifications of the different markers in this pathology. Serum type I collagen and PIIINP were decreased. Serum hyaluronan, linked to perilymphatic granulomatous inflammation, was significantly increased in acute lymphangitis and elephantiasis patients. Serum ECP was also increased, at the limit of significance in our sample, in elephantiasis patients. These two last markers, already validated in another helminth disease, schistosomiasis, have potential interest in terms of follow-up of morbidity in these parasitic diseases.
DOI: 10.1051/parasite/2006132165
PubMed: 16800126
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :003957
Links to Exploration step
pubmed:16800126Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Circulating fibrosis markers, eosinophil cationic protein and eosinophil protein X in patients with Wuchereria bancrofti infection: association with clinical status.</title>
<author><name sortKey="Esterre, P" sort="Esterre, P" uniqKey="Esterre P" first="P" last="Esterre">P. Esterre</name>
<affiliation wicri:level="1"><nlm:affiliation>Immunology Unit, Institut de recherches médicales Malardé, Papeete, Tahiti, French Polynesia. pesterre@pasteur-cayenne.fr</nlm:affiliation>
<country xml:lang="fr">Polynésie française</country>
<wicri:regionArea>Immunology Unit, Institut de recherches médicales Malardé, Papeete, Tahiti</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Plichart, C" sort="Plichart, C" uniqKey="Plichart C" first="C" last="Plichart">C. Plichart</name>
</author>
<author><name sortKey="Huin Blondey, M O" sort="Huin Blondey, M O" uniqKey="Huin Blondey M" first="M O" last="Huin-Blondey">M O Huin-Blondey</name>
</author>
<author><name sortKey="Nguyen, L N" sort="Nguyen, L N" uniqKey="Nguyen L" first="L N" last="Nguyen">L N Nguyen</name>
</author>
<author><name sortKey="Hartmann, D" sort="Hartmann, D" uniqKey="Hartmann D" first="D" last="Hartmann">D. Hartmann</name>
</author>
<author><name sortKey="Guerret, S" sort="Guerret, S" uniqKey="Guerret S" first="S" last="Guerret">S. Guerret</name>
</author>
<author><name sortKey="Reimert, C M" sort="Reimert, C M" uniqKey="Reimert C" first="C M" last="Reimert">C M Reimert</name>
</author>
<author><name sortKey="Ricard Blum, S" sort="Ricard Blum, S" uniqKey="Ricard Blum S" first="S" last="Ricard-Blum">S. Ricard-Blum</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2006">2006</date>
<idno type="RBID">pubmed:16800126</idno>
<idno type="pmid">16800126</idno>
<idno type="doi">10.1051/parasite/2006132165</idno>
<idno type="wicri:Area/PubMed/Corpus">003957</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">003957</idno>
<idno type="wicri:Area/PubMed/Curation">003957</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">003957</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Circulating fibrosis markers, eosinophil cationic protein and eosinophil protein X in patients with Wuchereria bancrofti infection: association with clinical status.</title>
<author><name sortKey="Esterre, P" sort="Esterre, P" uniqKey="Esterre P" first="P" last="Esterre">P. Esterre</name>
<affiliation wicri:level="1"><nlm:affiliation>Immunology Unit, Institut de recherches médicales Malardé, Papeete, Tahiti, French Polynesia. pesterre@pasteur-cayenne.fr</nlm:affiliation>
<country xml:lang="fr">Polynésie française</country>
<wicri:regionArea>Immunology Unit, Institut de recherches médicales Malardé, Papeete, Tahiti</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Plichart, C" sort="Plichart, C" uniqKey="Plichart C" first="C" last="Plichart">C. Plichart</name>
</author>
<author><name sortKey="Huin Blondey, M O" sort="Huin Blondey, M O" uniqKey="Huin Blondey M" first="M O" last="Huin-Blondey">M O Huin-Blondey</name>
</author>
<author><name sortKey="Nguyen, L N" sort="Nguyen, L N" uniqKey="Nguyen L" first="L N" last="Nguyen">L N Nguyen</name>
</author>
<author><name sortKey="Hartmann, D" sort="Hartmann, D" uniqKey="Hartmann D" first="D" last="Hartmann">D. Hartmann</name>
</author>
<author><name sortKey="Guerret, S" sort="Guerret, S" uniqKey="Guerret S" first="S" last="Guerret">S. Guerret</name>
</author>
<author><name sortKey="Reimert, C M" sort="Reimert, C M" uniqKey="Reimert C" first="C M" last="Reimert">C M Reimert</name>
</author>
<author><name sortKey="Ricard Blum, S" sort="Ricard Blum, S" uniqKey="Ricard Blum S" first="S" last="Ricard-Blum">S. Ricard-Blum</name>
</author>
</analytic>
<series><title level="j">Parasite (Paris, France)</title>
<idno type="ISSN">1252-607X</idno>
<imprint><date when="2006" type="published">2006</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term>
<term>Animals</term>
<term>Biomarkers (blood)</term>
<term>Elephantiasis, Filarial (blood)</term>
<term>Elephantiasis, Filarial (parasitology)</term>
<term>Elephantiasis, Filarial (pathology)</term>
<term>Enzyme-Linked Immunosorbent Assay</term>
<term>Eosinophil Cationic Protein (blood)</term>
<term>Eosinophil-Derived Neurotoxin (blood)</term>
<term>Female</term>
<term>Fibrosis</term>
<term>Filariasis (blood)</term>
<term>Filariasis (parasitology)</term>
<term>Filariasis (pathology)</term>
<term>Humans</term>
<term>Immunologic Factors (blood)</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Polynesia</term>
<term>Wuchereria bancrofti (immunology)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Adulte</term>
<term>Adulte d'âge moyen</term>
<term>Animaux</term>
<term>Facteurs immunologiques (sang)</term>
<term>Femelle</term>
<term>Fibrose</term>
<term>Filariose lymphatique (anatomopathologie)</term>
<term>Filariose lymphatique (parasitologie)</term>
<term>Filariose lymphatique (sang)</term>
<term>Filarioses (anatomopathologie)</term>
<term>Filarioses (parasitologie)</term>
<term>Filarioses (sang)</term>
<term>Humains</term>
<term>Marqueurs biologiques (sang)</term>
<term>Mâle</term>
<term>Neurotoxine dérivée des éosinophiles (sang)</term>
<term>Polynésie</term>
<term>Protéine cationique de l'éosinophile (sang)</term>
<term>Test ELISA</term>
<term>Wuchereria bancrofti (immunologie)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="blood" xml:lang="en"><term>Biomarkers</term>
<term>Eosinophil Cationic Protein</term>
<term>Eosinophil-Derived Neurotoxin</term>
<term>Immunologic Factors</term>
</keywords>
<keywords scheme="MESH" type="geographic" xml:lang="en"><term>Polynesia</term>
</keywords>
<keywords scheme="MESH" qualifier="anatomopathologie" xml:lang="fr"><term>Filariose lymphatique</term>
<term>Filarioses</term>
</keywords>
<keywords scheme="MESH" qualifier="blood" xml:lang="en"><term>Elephantiasis, Filarial</term>
<term>Filariasis</term>
</keywords>
<keywords scheme="MESH" qualifier="immunologie" xml:lang="fr"><term>Wuchereria bancrofti</term>
</keywords>
<keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>Wuchereria bancrofti</term>
</keywords>
<keywords scheme="MESH" qualifier="parasitologie" xml:lang="fr"><term>Filariose lymphatique</term>
<term>Filarioses</term>
</keywords>
<keywords scheme="MESH" qualifier="parasitology" xml:lang="en"><term>Elephantiasis, Filarial</term>
<term>Filariasis</term>
</keywords>
<keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Elephantiasis, Filarial</term>
<term>Filariasis</term>
</keywords>
<keywords scheme="MESH" qualifier="sang" xml:lang="fr"><term>Facteurs immunologiques</term>
<term>Filariose lymphatique</term>
<term>Filarioses</term>
<term>Marqueurs biologiques</term>
<term>Neurotoxine dérivée des éosinophiles</term>
<term>Protéine cationique de l'éosinophile</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Adult</term>
<term>Animals</term>
<term>Enzyme-Linked Immunosorbent Assay</term>
<term>Female</term>
<term>Fibrosis</term>
<term>Humans</term>
<term>Male</term>
<term>Middle Aged</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Adulte</term>
<term>Adulte d'âge moyen</term>
<term>Animaux</term>
<term>Femelle</term>
<term>Fibrose</term>
<term>Humains</term>
<term>Mâle</term>
<term>Polynésie</term>
<term>Test ELISA</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">We measured the concentrations of several circulating fibrosis markers (type I collagen I, type III procollagen, hyaluronan) and eosinophil granule proteins (ECP and EPX) in lymphatic filariosis patients to investigate their relationship with clinical, parasitological and immunological data. This study was conducted in Polynesian patients with various stages of the disease (acute lymphangitis, chyluria, hydrocoele, elephantiasis), a closely related microbial lymphangitis and endemic controls. We observed modifications of the different markers in this pathology. Serum type I collagen and PIIINP were decreased. Serum hyaluronan, linked to perilymphatic granulomatous inflammation, was significantly increased in acute lymphangitis and elephantiasis patients. Serum ECP was also increased, at the limit of significance in our sample, in elephantiasis patients. These two last markers, already validated in another helminth disease, schistosomiasis, have potential interest in terms of follow-up of morbidity in these parasitic diseases.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">16800126</PMID>
<DateCreated><Year>2006</Year>
<Month>06</Month>
<Day>27</Day>
</DateCreated>
<DateCompleted><Year>2006</Year>
<Month>08</Month>
<Day>16</Day>
</DateCompleted>
<DateRevised><Year>2017</Year>
<Month>02</Month>
<Day>07</Day>
</DateRevised>
<Article PubModel="Print"><Journal><ISSN IssnType="Print">1252-607X</ISSN>
<JournalIssue CitedMedium="Print"><Volume>13</Volume>
<Issue>2</Issue>
<PubDate><Year>2006</Year>
<Month>Jun</Month>
</PubDate>
</JournalIssue>
<Title>Parasite (Paris, France)</Title>
<ISOAbbreviation>Parasite</ISOAbbreviation>
</Journal>
<ArticleTitle>Circulating fibrosis markers, eosinophil cationic protein and eosinophil protein X in patients with Wuchereria bancrofti infection: association with clinical status.</ArticleTitle>
<Pagination><MedlinePgn>165-70</MedlinePgn>
</Pagination>
<Abstract><AbstractText>We measured the concentrations of several circulating fibrosis markers (type I collagen I, type III procollagen, hyaluronan) and eosinophil granule proteins (ECP and EPX) in lymphatic filariosis patients to investigate their relationship with clinical, parasitological and immunological data. This study was conducted in Polynesian patients with various stages of the disease (acute lymphangitis, chyluria, hydrocoele, elephantiasis), a closely related microbial lymphangitis and endemic controls. We observed modifications of the different markers in this pathology. Serum type I collagen and PIIINP were decreased. Serum hyaluronan, linked to perilymphatic granulomatous inflammation, was significantly increased in acute lymphangitis and elephantiasis patients. Serum ECP was also increased, at the limit of significance in our sample, in elephantiasis patients. These two last markers, already validated in another helminth disease, schistosomiasis, have potential interest in terms of follow-up of morbidity in these parasitic diseases.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Esterre</LastName>
<ForeName>P</ForeName>
<Initials>P</Initials>
<AffiliationInfo><Affiliation>Immunology Unit, Institut de recherches médicales Malardé, Papeete, Tahiti, French Polynesia. pesterre@pasteur-cayenne.fr</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Plichart</LastName>
<ForeName>C</ForeName>
<Initials>C</Initials>
</Author>
<Author ValidYN="Y"><LastName>Huin-Blondey</LastName>
<ForeName>M O</ForeName>
<Initials>MO</Initials>
</Author>
<Author ValidYN="Y"><LastName>Nguyen</LastName>
<ForeName>L N</ForeName>
<Initials>LN</Initials>
</Author>
<Author ValidYN="Y"><LastName>Hartmann</LastName>
<ForeName>D</ForeName>
<Initials>D</Initials>
</Author>
<Author ValidYN="Y"><LastName>Guerret</LastName>
<ForeName>S</ForeName>
<Initials>S</Initials>
</Author>
<Author ValidYN="Y"><LastName>Reimert</LastName>
<ForeName>C M</ForeName>
<Initials>CM</Initials>
</Author>
<Author ValidYN="Y"><LastName>Ricard-Blum</LastName>
<ForeName>S</ForeName>
<Initials>S</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo><Country>France</Country>
<MedlineTA>Parasite</MedlineTA>
<NlmUniqueID>9437094</NlmUniqueID>
<ISSNLinking>1252-607X</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D007155">Immunologic Factors</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>EC 3.1.-</RegistryNumber>
<NameOfSubstance UI="D047208">Eosinophil-Derived Neurotoxin</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>EC 3.1.27.-</RegistryNumber>
<NameOfSubstance UI="D047150">Eosinophil Cationic Protein</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName>
<QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D004605" MajorTopicYN="N">Elephantiasis, Filarial</DescriptorName>
<QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName>
<QualifierName UI="Q000469" MajorTopicYN="N">parasitology</QualifierName>
<QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D004797" MajorTopicYN="N">Enzyme-Linked Immunosorbent Assay</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D047150" MajorTopicYN="N">Eosinophil Cationic Protein</DescriptorName>
<QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D047208" MajorTopicYN="N">Eosinophil-Derived Neurotoxin</DescriptorName>
<QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005355" MajorTopicYN="N">Fibrosis</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005368" MajorTopicYN="N">Filariasis</DescriptorName>
<QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName>
<QualifierName UI="Q000469" MajorTopicYN="N">parasitology</QualifierName>
<QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007155" MajorTopicYN="N">Immunologic Factors</DescriptorName>
<QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011114" MajorTopicYN="N" Type="Geographic">Polynesia</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D014958" MajorTopicYN="Y">Wuchereria bancrofti</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2006</Year>
<Month>6</Month>
<Day>28</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2006</Year>
<Month>8</Month>
<Day>17</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2006</Year>
<Month>6</Month>
<Day>28</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">16800126</ArticleId>
<ArticleId IdType="doi">10.1051/parasite/2006132165</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/PubMed/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003957 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 003957 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Sante |area= LymphedemaV1 |flux= PubMed |étape= Curation |type= RBID |clé= pubmed:16800126 |texte= Circulating fibrosis markers, eosinophil cationic protein and eosinophil protein X in patients with Wuchereria bancrofti infection: association with clinical status. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i -Sk "pubmed:16800126" \ | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd \ | NlmPubMed2Wicri -a LymphedemaV1
This area was generated with Dilib version V0.6.31. |